Cargando…

Evolution, Mode of Transmission, and Mutational Landscape of Newly Emerging SARS-CoV-2 Variants

The recent emergence of multiple variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a significant concern for public health worldwide. New variants have been classified either as variants of concern (VOCs) or variants of interest (VOIs) by the CDC (USA) and WHO. The...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chakraborty, Chiranjib, Sharma, Ashish Ranjan, Bhattacharya, Manojit, Agoramoorthy, Govindasamy, Lee, Sang-Soo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406297/ https://www.ncbi.nlm.nih.gov/pubmed/34465019 http://dx.doi.org/10.1128/mBio.01140-21

Ejemplares similares

A comprehensive analysis of the mutational landscape of the newly emerging Omicron (B.1.1.529) variant and comparison of mutations with VOCs and VOIs
por: Chakraborty, Chiranjib, et al.
Publicado: (2022)

A Paradigm Shift in the Combination Changes of SARS-CoV-2 Variants and Increased Spread of Delta Variant (B.1.617.2) across the World
por: Chakraborty, Chiranjib, et al.
Publicado: (2022)

Omicron variant (B.1.1.529) of SARS-CoV-2: understanding mutations in the genome, S-glycoprotein, and antibody-binding regions
por: Bhattacharya, Manojit, et al.
Publicado: (2022)

Evolution, epidemiology, geographical distribution, and mutational landscape of newly emerging monkeypox virus
por: Chakraborty, Chiranjib, et al.
Publicado: (2022)

SARS-CoV-2 Brazil variants in Latin America: More serious research urgently needed on public health and vaccine protection
por: Chakraborty, Chiranjib, et al.
Publicado: (2021)

Structural Landscape of nsp Coding Genomic Regions of SARS-CoV-2-ssRNA Genome: A Structural Genomics Approach Toward Identification of Druggable Genome, Ligand-Binding Pockets, and Structure-Based Druggability
por: Chakraborty, Chiranjib, et al.
Publicado: (2022)

D614G mutation and SARS-CoV-2: impact on S-protein structure, function, infectivity, and immunity
por: Bhattacharya, Manojit, et al.
Publicado: (2021)

D614G mutation eventuates in all VOI and VOC in SARS-CoV-2: Is it part of the positive selection pioneered by Darwin?
por: Chakraborty, Chiranjib, et al.
Publicado: (2021)

The Drug Repurposing for COVID-19 Clinical Trials Provide Very Effective Therapeutic Combinations: Lessons Learned From Major Clinical Studies
por: Chakraborty, Chiranjib, et al.
Publicado: (2021)

The current second wave and COVID-19 vaccination status in India
por: Chakraborty, Chiranjib, et al.
Publicado: (2021)

All Nations Must Prioritize the COVID-19 Vaccination Program for Elderly Adults Urgently
por: Chakraborty, Chiranjib, et al.
Publicado: (2021)

Asian-Origin Approved COVID-19 Vaccines and Current Status of COVID-19 Vaccination Program in Asia: A Critical Analysis
por: Chakraborty, Chiranjib, et al.
Publicado: (2021)

Delta variant (B.1.617.2) of SARS-CoV-2: current understanding of infection, transmission, immune escape, and mutational landscape
por: Bhattacharya, Manojit, et al.
Publicado: (2022)

Hybrid immunity against COVID-19 in different countries with a special emphasis on the Indian scenario during the Omicron period
por: Bhattacharya, Manojit, et al.
Publicado: (2022)

Natural selection of the D614G mutation in SARS-CoV-2 Omicron (B.1.1.529) variant and its subvariants
por: Chakraborty, Chiranjib, et al.
Publicado: (2023)

Artificial intelligence–enabled clinical trials might be a faster way to perform rapid clinical trials and counter future pandemics: lessons learned from the COVID-19 period
por: Chakraborty, Chiranjib, et al.
Publicado: (2023)

A Detailed Overview of Immune Escape, Antibody Escape, Partial Vaccine Escape of SARS-CoV-2 and Their Emerging Variants With Escape Mutations
por: Chakraborty, Chiranjib, et al.
Publicado: (2022)

Integrative Bioinformatics Approaches Indicate a Particular Pattern of Some SARS-CoV-2 and Non-SARS-CoV-2 Proteins
por: Chakraborty, Chiranjib, et al.
Publicado: (2022)

Emerging mutations in the SARS-CoV-2 variants and their role in antibody escape to small molecule-based therapeutic resistance
por: Chakraborty, Chiranjib, et al.
Publicado: (2022)

From COVID-19 to Cancer mRNA Vaccines: Moving From Bench to Clinic in the Vaccine Landscape
por: Chakraborty, Chiranjib, et al.
Publicado: (2021)

Omicron (B.1.1.529) - A new heavily mutated variant: Mapped location and probable properties of its mutations with an emphasis on S-glycoprotein
por: Chakraborty, Chiranjib, et al.
Publicado: (2022)

Stem cells in the light of evolution
por: Chakraborty, Chiranjib, et al.
Publicado: (2012)

SARS-CoV-2 and other human coronaviruses: Mapping of protease recognition sites, antigenic variation of spike protein and their grouping through molecular phylogenetics
por: Chakraborty, Chiranjib, et al.
Publicado: (2021)

Insight into Evolution and Conservation Patterns of B1-Subfamily Members of GPCR
por: Chakraborty, Chiranjib, et al.
Publicado: (2020)

Appearance and re-appearance of zoonotic disease during the pandemic period: long-term monitoring and analysis of zoonosis is crucial to confirm the animal origin of SARS-CoV-2 and monkeypox virus
por: Chakraborty, Chiranjib, et al.
Publicado: (2022)

Monkeypox virus vaccine evolution and global preparedness for vaccination
por: Chakraborty, Chiranjib, et al.
Publicado: (2022)

Recombinant SARS-CoV-2 variants XD, XE, and XF: The emergence of recombinant variants requires an urgent call for research – Correspondence
por: Chakraborty, Chiranjib, et al.
Publicado: (2022)

Continent-wide evolutionary trends of emerging SARS-CoV-2 variants: dynamic profiles from Alpha to Omicron
por: Chakraborty, Chiranjib, et al.
Publicado: (2022)

A Next-Generation Vaccine Candidate Using Alternative Epitopes to Protect against Wuhan and All Significant Mutant Variants of SARS-CoV-2: An Immunoinformatics Approach
por: Bhattacharya, Manojit, et al.
Publicado: (2021)

Lessons Learned from Cutting-Edge Immunoinformatics on Next-Generation COVID-19 Vaccine Research
por: Chakraborty, Chiranjib, et al.
Publicado: (2021)

B.1.1.7 (Alpha) variant is the most antigenic compared to Wuhan strain, B.1.351, B.1.1.28/triple mutant and B.1.429 variants
por: Bhattacharya, Manojit, et al.
Publicado: (2022)

MicroRNAs: Possible Regulatory Molecular Switch Controlling the BBB Microenvironment
por: Chakraborty, Chiranjib, et al.
Publicado: (2020)

Immunoinformatics Approach for the Identification and Characterization of T Cell and B Cell Epitopes towards the Peptide-Based Vaccine against SARS-CoV-2
por: Chakraborty, Chiranjib, et al.
Publicado: (2021)

Immediate need for next-generation and mutation-proof vaccine to protect against current emerging Omicron sublineages and future SARS-CoV-2 variants: An urgent call for researchers and vaccine companies – Correspondence
por: Chakraborty, Chiranjib, et al.
Publicado: (2022)

Therapeutic Role of Neutralizing Antibody for the Treatment against SARS-CoV-2 and Its Emerging Variants: A Clinical and Pre-Clinical Perspective
por: Bhattacharya, Manojit, et al.
Publicado: (2022)

India’s cost-effective COVID-19 vaccine development initiatives
por: Chakraborty, Chiranjib, et al.
Publicado: (2020)

Landscape Mapping of Functional Proteins in Insulin Signal Transduction and Insulin Resistance: A Network-Based Protein-Protein Interaction Analysis
por: Chakraborty, Chiranjib, et al.
Publicado: (2011)

Understanding Gene Expression and Transcriptome Profiling of COVID-19: An Initiative Towards the Mapping of Protective Immunity Genes Against SARS-CoV-2 Infection
por: Chakraborty, Chiranjib, et al.
Publicado: (2021)

Altered gut microbiota patterns in COVID-19: Markers for inflammation and disease severity
por: Chakraborty, Chiranjib, et al.
Publicado: (2022)

Quantum Computing in the Next-Generation Computational Biology Landscape: From Protein Folding to Molecular Dynamics
por: Pal, Soumen, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_i6pdtqif3c407dsm44ovd9ohg0